Suivez les dernières activités de délit d'initié Rapport Therapeutics. Restez informé des achats, des ventes et de l'impact sur le marché des actions Rapport Therapeutics.
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
À Rapport Therapeutics Inc, une activité interne récente a attiré l'attention. Au cours des 30 derniers jours, les initiés ont déclaré avoir vendu un total de 95.84K actions d'une valeur de $2.51M. ne signalez aucun achat au cours des 30 derniers jours.
Oct 16, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $25.79 | -$219.20K | SELL | -2.03% | 409.64K | Oct 15 | ||
Oct 16, 2025 | CHIEF EXECUTIVE OFFICER | -10.92K | $25.81 | -$281.73K | SELL | -8.16% | 122.79K | Oct 15 | ||
Sep 19, 2025 | CHIEF EXECUTIVE OFFICER | -76.42K | $26.32 | -$2.01M | SELL | -37.41% | 127.87K | Sep 17 | ||
Sep 17, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $24.19 | -$205.65K | SELL | -1.99% | 418.14K | Sep 15 | ||
Sep 15, 2025 | — | 20.40K | $24.48 | $499.37K | BUY | ∞ | 20.40K | Sep 12 | ||
Sep 15, 2025 | — | 41.67K | $24.65 | $1.03M | BUY | ∞ | 41.67K | Sep 12 | ||
Sep 11, 2025 | — | 3.50K | $22.60 | $79.10K | BUY | 58.33% | 9.50K | Sep 11 | ||
Sep 10, 2025 | CHIEF OPERATING OFFICER | 0.00 | $20.06 | -$182.65K | SELL-OPTIONS | 0.00% | 171.93K | Sep 08 | ||
Aug 18, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $15.00 | -$127.47K | SELL | -1.95% | 426.64K | Aug 15 | ||
Jul 16, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $14.00 | -$118.96K | SELL | -1.92% | 435.14K | Jul 15 | ||
Jun 18, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $11.00 | -$93.52K | SELL | -1.88% | 443.64K | Jun 16 | ||
May 19, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $9.56 | -$81.26K | SELL | -1.85% | 452.14K | May 15 | ||
Apr 16, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $9.57 | -$81.31K | SELL | -1.81% | 460.64K | Apr 15 | ||
Mar 17, 2025 | CHIEF SCIENTIFIC OFFICER | -8.50K | $10.85 | -$92.21K | SELL | -1.78% | 469.14K | Mar 14 | ||
Mar 13, 2025 | CHIEF FINANCIAL OFFICER | 10.00K | $10.10 | $100.99K | BUY | ∞ | 10.00K | Mar 12 - Mar 13 | ||
Mar 13, 2025 | — | 6.00K | $10.21 | $61.25K | BUY | ∞ | 6.00K | Mar 12 | ||
Jul 03, 2024 | DIRECTOR | 44.03K | $24.52 | $1.08M | BUY | 284.81% | 59.49K | Jul 01 | ||
Jun 10, 2024 | — | 1.95M | $17.00 | $9.50M | BUY | ∞ | 25.45K | Jun 10 |
Parcourir transactions d'initiés sur toutes les actions.